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Introduction : Brain tumor is a disease with high morbidity and mortality rates. Treating brain tumors 
requiring medical providers to have basic understanding of brain tumor diagnosis and management. The 
most common brain tumors are meningiomas, gliomas, pituitary adenomas and brain metastasis. The 
treatment of each type of brain tumor is different and  multidisciplinary involving other scientific fields 
besides neurosurgery.  
Case Series : We reported 131 cases of brain tumors at the Haji Adam Malik Hospital in the period 
January 2018-December 2019, consisting of 52 cases (40%) of meningioma, 34 cases (26%) of Glioma , 
12 cases (9%) of pituitary adenomas and 33 cases (25%) of brain metastasis. Meningiomas were mostly 
treated with surgery alone in 38% of cases, gliomas with surgery followed by chemo-radiation in 41% of 
cases, all of pituitary adenomas were treated with endonasal transfenoid surgery, while brain metastasis in 
70% of cases required whole brain radiation with controlled primary tumors. 
Discussion : The modalities for treating brain tumor patients has been increasing recently. Meningiomas 
are mostly benign and managed by surgical resection only, chemo-radiation reserved for high risk or 
refractory case of meningiomas. Glioblastoma is the most common glioma and aggressive malignant 
primary brain tumor, limited response to gross surgical tumor and chemo-radiation. Pituitary adenomas 
mostly treated with endonasal transfenoid surgery, radiotherapy use in recurrent case. Brain metastasis 
may require complex multidisciplinary care with neurosurgery, radiation oncology, and medical 
oncology. 
Conclusion: The treatment of brain tumors is influenced by various considerations such as age, patient 
condition,neurological deficits, location of the tumor, comorbidities, experience of the neurosurgeon and 
available modalities. Treatment methods for brain tumors continue to evolve. 
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Introduction 
Brain tumors refers to a mixed group of neoplasms originating from intracranial 
parenchym and meninges with degrees of malignancy ranging from benign to 
aggressive. Each type of tumour has its own biology, treatment, and prognosis and each 
is likely to be caused by different risk factors. Brain tumor is a disease with high 
morbidity and mortality rates. [1] 
In the current era, where life expectancy is increasing, the incidence of brain 
tumors is also increasing. Technological developments have also helped early detection 
of brain tumors, because of that the number of cases found has also increased. World 
data state that the annual global age standardized incidence of primary malignant brain 
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tumors is 3.7 per 100,000 for males and 2.6 per 100,000 for females. Rates appear to be 
higher more developed countries than in less developed countries. Approximately 
20,500 individuals (11,170 males and 9,330 females) were diagnosed with primary 
malignant brain tumors in 2007 in the US. [2], [3] 
Treating brain tumors requiring medical providers to have basic understanding 
of brain tumor diagnosis and management. The most common brain tumors are 
meningiomas, gliomas, pituitary adenomas and brain metastasis. The treatment of each 
type of brain tumor is different and  multidisciplinary involving other scientific fields 
besides neurosurgery. [1], [2] 
This paper discusses about the development and experience of treatment in brain 
tumor cases at General Hospital Haji Adam Malik Medan. This paper will describe the 
types of brain tumors that were found. Then it will also explain about the demography 




This study is a descriptive study that describes the types of brain tumors 
obtained at the Haji Adam Malik General Hospital Medan during the 2018-2019 period. 
This study analyzed the type of brain tumor, the demographics of the sample, the 
histopathological results and the treatment selected for each type of brain tumor. 
We reported 131 cases of brain tumors at the Haji Adam Malik Hospital in the 
period January 2018-December 2019, consisting of 52 cases (40%) of meningioma, 34 
cases (26%) of Glioma , 12 cases (9%) of pituitary adenomas and 33 cases (25%) of 
brain metastasis.  
Table 1. Type of Brain Tumor 
 
Brain Tumor Type Number of Cases Percentage 
Meningiomas 52 40% 
Gliomas 34 26% 
Pituitary Adenomas 12 9% 
Brain Metastasis 33 25% 
Total 131 100% 
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Based on demographic data obtained, the most age in cases of meningioma and 
glioma is age between 51-60 years, the most age in pituitary cases is 41-50 years, while 
brain metastases mostly at age > 60 years. Most of the gender in all brain tumor types 
are male. Most of the sample GCS condition was GCS 14-15, with Karnofsky 
Performance Score > 60. 
  
Table 2. Demographic of Patients 





20-30 - - - - 
31-40 2 2 - - 
41-50 20 7 6 5 
51-60 26 22 5 14 
> 60 4 3 1 14 
Gender 
Male 30 20 9 20 
Female 22 14 3 13 
GCS 
3-8 - 2 - 3 
9-12 4 4 - 10 
13-15 48 28 12 20 
KPS 
< 60 6 10 - 8 
> 60 46 24 12 25 
Total 52 34 12 33 
 
Based on the choice of treatment, meningiomas were mostly treated with surgery 
alone in 38% of cases. Gliomas with surgery followed by chemo-radiation in 41% of 
cases,especially in high grade glioma cases. All of pituitary adenomas were treated with 
endonasal transfenoid surgery, while brain metastasis in 70% of cases required whole 
brain radiation with controlled primary tumors. 
Based on the results of histopathological examination, it was found that most of 
meningiomas was grade I (73%). High grade glioma was found in 59% of glioma cases. 
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Primary tumors that cause brain metastases mostly originate from the lungs cancer 
(45%). 
 
Table 3. Histopathology of Brain Tumor 
 
Brain Tumor Type Number of Cases Percentage 
Meningioma  
Grade I 38 73% 
Grade II 12 23% 
Grade III 2 4% 
Glioma  
Low Grade 14 41% 
High Grade 20 59% 
Pituitary Adenomas  
Source of Brain metastasis  
Lung 15 45% 
Breast  10 30% 
Thyroid 3 9% 
Gastro-Intestinal Tract 2 7% 
Other 3 9% 
 
 
Table 4. Treatment Based on Brain Tumor Type 
 
Brain Tumor  Treatment 




Meningioma - 38 (73%) 14 (27%) - 














There have been reports of increasing incidence of primary brain tumours in 
recent decades which need to be interpreted with caution. Trends over time can only be 
considered valid when based upon data collected according to the same definitions and 
reporting practice. Inconsistencies and changes over time may be the explanation for the 
observed rises which have been attributed to various factors. Improved diagnostic 
imaging, following introduction of radio isotope imaging computed tomography, and 
magnetic resonance imaging in the 1970s and 1980s, will have resulted in higher 
detection rates and better differential diagnosis of brain tumours which might have 
previously been diagnosed as strokes or metastatic tumours. Access to services will 
have improved, making it more likely that a patient with a tumour is registered. In 
addition, histopathological technology has increased the specificity of tumour diagnosis 
and thus an apparent increase in specific tumour types. [4], [5] 
Meningiomas are believed to derive from the arachnoid cap cells around 
arachnoid granulations near venous sinuses, cisterns, ventricles, and brain. They can be 
found anywhere there is known pia, arachnoid, or dura. These tumors exhibit a wide 
variety of behaviors from benign to extremely aggressive A wide spectrum of surgical 
approaches can be employed to radically excise a meningioma. Preoperative 
embolization can decrease intraoperative blood loss in selected patients. Postoperative 
radiation therapy, radiosurgery, and hormonal therapy is required for incompletely 
resected lesions or those with malignant characteristics.[6], [7] 
In glioma cases, the extent of surgical resection probably correlates with a better 
survival, but resection must be tempered by their location close to the eloquent area. 
Motor-sensory mapping, language mapping, and diffusion tensor imaging should be 
used to assess tumors adjacent to critical regions.[6], [8]. Factors such as a younger age 
group, lower tumor histological grade, and higher KPS score are associated with a better 
prognosis for gliomas. The extent of resection has a probable influence on survival. 
Both radiotherapy and temozolomide chemotherapy significantly increase survival time 
of these patients. [9] 
Pituitary tumors present in various ways as a result of excess or deficient 
secretion of pituitary hormones or extrinsic compression on the pituitary stalk or 
adjacent structures. Approximately 75% of pituitary adenomas are functioning tumors. 
Transsphenoidal adenomectomy  is the first line of treatment. Medical therapy is the 
first line of treatment for prolactinomas. Other functioning adenomas generally require 
surgical resection, medical treatment, or radiation therapy for recurrent case. Surgery 
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through the microscopic, extended transsphenoidal, or endoscopic route is safe and 
effective in experienced hands. Craniotomy may be required for a tumor extending 
beyond the sellar region.[6], [10] 
Cerebral metastatic disease represents a serious progression of systemic cancer 
Therapies for brain metastases are roughly equivalent, with local recurrence rate of 40% 
to 50% at 1 year. Therefore, the choice of therapy must be tailored to the individual 
patient, taking into account Karnofsky performance scale (KPS) score, medical 
comorbid conditions, systemic disease status, number of metastases, size and location of 
metastases, and symptoms. As long as brain metastases undergo some form of 
treatment, the vast majority of patients will succumb to progression of systemic disease 
as opposed to brain metastases.It is essential that treatment decisions for this lethal 
disease be made as a multidisciplinary team of oncologists, radiation oncologists, and 
neurosurgeons, as well as the patient and the patient’s family. .Currently, the most 
effective options for treatment of cerebral metastatic disease include whole-brain 
radiation therapy, surgical resection, and stereotactic radiosurgery.[6], [11] 
 
Conclusion 
 We reported 131 cases of brain tumors at the Haji Adam Malik Hospital in the 
period January 2018-December 2019. These cases consisted of several types of brain 
tumors, namely, meningiomas, gliomas, pituitary adenomas and brain metastases.The 
treatment of brain tumors is influenced by various considerations such as age, patient 
condition,neurological deficits, location of the tumor, comorbidities, experience of the 
neurosurgeon and available modalities.  
The modalities for treating brain tumor patients has been increasing recently. 
Meningiomas are mostly benign and managed by surgical resection only, chemo-
radiation reserved for high risk or refractory case of meningiomas. Glioblastoma is the 
most common glioma and aggressive malignant primary brain tumor, limited response 
to gross surgical tumor and chemo-radiation. Pituitary adenomas mostly treated with 
endonasal transfenoid surgery, radiotherapy use in recurrent case. Brain metastasis may 
require complex multidisciplinary care with neurosurgery, radiation oncology, and 
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